Data / Drug companies / Chongqing Huapont Shengchem Pharm. Co., LTD.
Chongqing Huapont Shengchem Pharm. Co., LTD.: 25 products in the FDA NDC directory, labeler code 48943
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Chongqing Huapont Shengchem Pharm. Co., LTD. (labeler code 48943) lists 25 products in the FDA National Drug Code Directory. By type: 25 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on February 9, 2026.
The request: Watch Chongqing Huapont Shengchem Pharm. Co., LTD. (FDA labeler code 48943): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 48943
- Products in commercial distribution
- 25
- Packages
- 63
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 3
- Earliest marketing start
- January 1, 2000
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 21 | 84% |
| Bulk ingredients for compounding | 4 | 16% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 25 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 25 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Adapalene | 48943-0042 | Powder | Bulk ingredients | February 9, 2026 |
| Moxifloxacin hcl | 48943-0041 | Powder | Bulk ingredients for compounding | December 1, 2025 |
| Isoniazid | 48943-0039 | Powder | Bulk ingredients | December 1, 2025 |
| Acitretin | 48943-0040 | Powder | Bulk ingredients for compounding | November 1, 2025 |
| Methoxsalen | 48943-0038 | Powder | Bulk ingredients | September 25, 2025 |
| Nintedanib esilate | 48943-0037 | Powder | Bulk ingredients | April 2, 2025 |
| Tazarotene | 48943-0036 | Powder | Bulk ingredients for compounding | January 21, 2025 |
| Tretinoin | 48943-0016 | Powder | Bulk ingredients for compounding | December 31, 2024 |
| Acrivastine | 48943-0035 | Powder | Bulk ingredients | August 21, 2023 |
| Ruxolitinib phosphate | 48943-0034 | Powder | Bulk ingredients | August 21, 2023 |
| Paricalcitol | 48943-0033 | Powder | Bulk ingredients | January 14, 2022 |
| Tazarotene | 48943-0027 | Powder | Bulk ingredients | June 3, 2021 |
| Calcipotriene anhydrous | 48943-0032 | Powder | Bulk ingredients | June 9, 2016 |
| Calcipotriene monohydrate | 48943-0030 | Powder | Bulk ingredients | June 9, 2016 |
| Calcipotriene anhydrous | 48943-0026 | Powder | Bulk ingredients | June 9, 2016 |
| Calcipotriene monohydrate | 48943-0023 | Powder | Bulk ingredients | June 9, 2016 |
| Calcipotriene anhydrous | 48943-0022 | Powder | Bulk ingredients | June 9, 2016 |
| Micronized bexarotene | 48943-0014 | Powder | Bulk ingredients | March 31, 2011 |
| Tetrandrine | 48943-0015 | Powder | Bulk ingredients | March 10, 2011 |
| Bexarotene | 48943-0013 | Powder | Bulk ingredients | March 10, 2011 |
| Alitretinoin | 48943-0012 | Powder | Bulk ingredients | March 10, 2011 |
| Bendamustine hydrochloride | 48943-0019 | Powder | Bulk ingredients | March 1, 2009 |
| Isotretinoin | 48943-0010 | Powder | Bulk ingredients | January 1, 2003 |
| Moxifloxacin hydrochloride | 48943-0024 | Powder | Bulk ingredients | November 30, 2002 |
| Tretinoin | 48943-0011 | Powder | Bulk ingredients | January 1, 2000 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.